# Company Context

Key facts about Sanctura relevant to the Medical Advisory Committee.

## About Sanctura

Sanctura is an international healthcare brand specialising in integrative cancer care, combining conventional oncology with evidence-based supportive therapies.

## Corporate Structure

- **Sanctura Holdings (UK)** — Parent company, owned 50/50 by Dr James Laporta and Capricorn Capital (Patrick Snelgar's investment firm)
- **Sanctura Ltd (UK)** — Operates the London clinic
- **St. Raphael (Pty) Ltd & Dr. James Laporta Inc (SA)** — Cape Town clinic operations

## Leadership & Board

| Role | Name |
|------|------|
| Founder & Medical Director | Dr James Laporta |
| Managing Director | Grant Merwitz |
| Chief Project Officer | Yaseen Harneker |
| Board Representative (Capricorn) | Andrew Newton |
| Board Rep & Account Manager | Ricardo Delgado |

## UK Clinic Status

- London clinic in operation for less than one year
- Successfully secured **CQC (Care Quality Commission) licence**
- Strategic partnerships with Dr Wendy Denning and Professor Justin Stebbing
- Current team: Practice Manager, four nurses, reception staff
- **Key gap:** Needs a permanent GMC-registered doctor following departure of previous NHS-based practitioner

## Clinical Services

- Hyperthermia & Photodynamic Therapy (PDT)
- Hyperbaric Oxygen Therapy (HBOT)
- Photobiomodulation Therapy
- IV Vitamin & Supplement Infusions
- Chemotherapy & Immunology (where jurisdictionally permitted)
- MDT Case Reviews & Specialist Consultations

## Current Phase

Sanctura is in a phase of **stabilisation and specialised recruitment**, scaling UK patient capacity following CQC licensing.
